Top Markets
Coin of the day
Medeon Biodesign, Inc. Medeon Biodesign, Inc.

Medeon Biodesign, Inc.

6499
Rang in Aktien #17676
Medeon Biodesign, Inc. engages in the research and development, manufacturing,... Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is engaged in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is based in Taipei, Taiwan.
Aktienkurs
$2.38
Marktkapitalisierung
$231.21M
Veränderung (1 Tag)
0.94%
Veränderung (1 Jahr)
-25.60%
Land
TW
Handel Medeon Biodesign, Inc. (6499)

Kategorie

Kursverlauf für Medeon Biodesign, Inc. (6499)
Höchster Schlusskurs: $2.37 am 2026-09-01

Niedrigster Schlusskurs: $3.72 am 2014-12-01
Kursverlauf der Aktie von Medeon Biodesign, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -6.33%
2025 138.73%
2024 -17.11%
2023 -15.33%
2022 -21.05%
2021 44.44%
2020 5.30%
2019 -21.32%
2018 2.21%
2017 -38.12%
2016 -41.50%
2015 38.47%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$325.17 41.55%
US
$173.39 250.21%
KR
$25.71 -4.87%
JP
$513.60 33.49%
JP
$3.59 -49.82%
CN